Ubiquitin C pseudogene

A **pseudogene** is a DNA sequence that closely resembles a functional gene (in this case, *ubiquitin C*) but has acquired mutations rendering it nonfunctional; it neither encodes a functional protein nor acts as a molecular therapeutic target[2][1]. Pseudogenes emerge through gene duplication, mutation, or via retrotransposition, and typically contain disruptions such as frame shifts, premature stop codons, or deletions, preventing normal gene expression and protein translation[2][1]. Most annotated pseudogenes, including the ubiquitin C pseudogene, do not produce protein products and are not considered relevant in drug targeting or biomarker discovery. Occasionally, some pseudogenes can have regulatory effects as noncoding RNAs, but such functions are exceptional rather than typical for this class[3]. Given these factors, the "ubiquitin C pseudogene" is **not a true drug target** and is more appropriately classified as a genomic relic rather than a receptor, enzyme, or signaling protein relevant to therapeutic intervention[2][3]. **Key clarifications:** - The entry is **not a molecular target** and annotation as a target is conceptually incorrect[2]. - No specific drugs, mechanisms of action, or safety concerns are associated.